Intellia Therapeutics News, Intellia Therapeutics Quote, NTLA Quote

Intellia Therapeutics (NQ:NTLA) Delayed: 15.67 +0.47 (3.09%)

Prev. Close

$15.20

Today 6M 1Y 5Y

Open

$15.52

52 Wk High

$30.40

52 Wk Low

$11.86

Day High

$16.20

Day Low

$15.04

P/E

N/A

EPS

$0.00

Volume

8,849,173

Friends, Peers and Foes (?): CRSP, BEAM, EDIT, DTIL, MGX (more...)

ALERTS | RSS

Jun 16, 2026 06:37 AM Canaccord Reiterates Buy Rating on Intellia Therapeutics (NTLA)
Jun 15, 2026 08:52 AM Form 8-K Intellia Therapeutics, For: Jun 13
Jun 15, 2026 06:48 AM H.C. Wainwright Reiterates Buy Rating on Intellia Therapeutics (NTLA)
Jun 15, 2026 05:41 AM Intellia Therapeutics (NTLA) Reiterated at Market Outperform by Citizens
Jun 13, 2026 07:30 AM Intellia reports positive Phase 3 results for hereditary angioedema treatment
Jun 13, 2026 07:30 AM Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Jun 10, 2026 07:08 PM Form 4 Intellia Therapeutics, For: Jun 09 Filed by: Verwiel Frank
Jun 10, 2026 07:07 PM Form 4 Intellia Therapeutics, For: Jun 09 Filed by: Keresty Georgia
Jun 10, 2026 07:06 PM Form 4 Intellia Therapeutics, For: Jun 09 Filed by: GOODMAN JESSE
Jun 10, 2026 07:03 PM Form 4 Intellia Therapeutics, For: Jun 09 Filed by: Goff Brian

Entities mentioned with NTLA

View All Entities